LD
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Optimizing oral targeted anticancer therapies study for patients with solid cancer: protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data | JMIR research protocols |  | 2021 | 146 | 78 | ||
| The steps to therapeutic drug monitoring: A structured approach illustrated with imatinib | Frontiers in Pharmacology | | 2020 | 296 | 146 | ||
| Therapeutic drug monitoring of targeted anticancer protein kinase inhibitors in routine clinical use: A critical review | Therapeutic Drug Monitoring |  | 2020 | 199 | 1 | ||
| Validation and Clinical Application of a Multiplex High Performance Liquid Chromatography - Tandem Mass Spectrometry Assay for the Monitoring of Plasma Concentrations of 12 Antibiotics in Patients with Severe Bacterial Infections | Journal of Chromatography. B | | 2020 | 242 | 85 | ||
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | | 2020 | 184 | 81 | ||
| Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry | Journal of Chromatography. B | | 2018 | 214 | 0 | ||
| Comparison against current standards of a DNA aptamer for the label-free quantification of tobramycin in human sera employed for therapeutic drug monitoring | Journal of Pharmaceutical and Biomedical Analysis | | 2018 | 200 | 2 | ||
| Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report | BMC gastroenterology | | 2015 | 699 | 259 | ||
| Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals | Pharmacogenetics and genomics | | 2013 | 558 | 0 | ||
| Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women | Antiviral therapy | | 2013 | 530 | 0 | ||
| Drug interactions between voriconazole, darunavir/ritonavir and etravirine in an HIV-infected patient with Aspergillus pneumonia | AIDS | | 2012 | 625 | 0 | ||
| Pharmacokinetics and pharmacogenomics of once-daily raltegravir and atazanavir in healthy volunteers | Antimicrobial agents and chemotherapy | | 2010 | 573 | 0 | ||
| Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir | AIDS | | 2010 | 570 | 0 | ||
| Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures | Journal of acquired immune deficiency syndromes | | 2010 | 587 | 0 | ||
| The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial | AIDS | | 2007 | 573 | 0 |
